You have no items in your shopping cart.
On Promotion
Category
Tested Applications
Conjugation
Featured Product
Search results for: 'Human CD3 epsilon'
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 12.79 KDa. Observed: 15-21 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mgSDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 14.6&16.0 KDa. Observed: 20&(22-38) KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 38.7 KDa. Observed: 40-50 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 37&38.3 KDa. Observed: 40-60 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 39.2&38.1 KDa. Observed: 40-60 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 37&39.2 KDa. Observed: 40-60 KDa, reducing conditions
10 μg, 500 μg, 50 μg, 1 mgBiotin
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 40.5 KDa. Observed: 45-60 KDa, reducing conditions
20 μg, 100 μgGreater than 95% as determined by reducing SDS-PAGE.
Predicted: 10.6&12.8 KDa. Observed: 16-30 KDa, reducing conditions
10 μg, 50 μg, 1 mg, 500 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 28.5 KDa. Observed: 32-40 KDa, reducing conditions
1 mg, 10 μg, 50 μg, 500 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 38 KDa. Observed: 38-55 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg